Aurobindo Pharma reported INR16.25B in EBIT for its fiscal quarter ending in September of 2026.





Ebit Change Date
Cipla INR 10.43B 1.55B Sep/2026
Divis Laboratories Ltd INR 14.24B 2.95B Sep/2026
Dr.Reddys Laboratories INR 12.16B 8.91B Sep/2026
Hindustan Unilever INR 37.26B 1.32B Sep/2026
Sun Pharmaceuticals INR 39.07B 3.5B Sep/2026
UPL INR 14.93B 8.25B Sep/2026